ࡱ> 796g LbjbjVV )r<r<BB84800000$$$$ z"00000)^08"!"!r"!$Z~@4$$$p$$$8"!$$$$$$$$$B b: Heparan Sulphate Catalogue no: GAG-HS01 BN1 Designation: Sodium Salt. Structure: Major disaccharide units: GlcA-GlcNAc and IdoA/GlcA-GlcNS (variable O-sulphation) Contains both low and high sulphated heparan sulphates. Quantity: 2mg Appearance: White powder Origin: Porcine Mucosa Toxicity and Hazards: We are not aware of any toxicity associated with this product. In common with good laboratory practice the material should only be handled by qualified personnel trained in laboratory procedures and familiar with potential hazards. These products are not intended for human consumption, drug use or any form of human experimentation. Applications: Biological, biochemical and biophysical laboratory research Storage: We do recommend that all products are stored frozen at 15 to 20 degrees Celsius upon receipt and that they are allowed to warm to room temperature before opening. If made up into solutions avoid repeated freeze-thawing. Stock solutions should be prepared in appropriate aliquots and stored frozen. Warranties: Iduron warrants that its products shall conform to the description of such products as provided in Idurons catalogue. This warranty is exclusive, and seller makes no other warranty, expressed or implied, including any implied warranty of merchantability or fitness for any particular purpose. See terms and conditions for further warranty information.     Product Data Sheet Iduron Ltd, Paterson Institute, Wilmslow Road. Manchester, M20 4BX, Uk, Email:info@iduron.co.uk Tel/Fax 0161 918 7030 !)-.:<HIRSTѾufZN>>hfB* CJOJQJaJphh :CJOJQJaJhbZCJOJQJaJh#hh#CJOJQJaJ#hCB*CJOJQJ^JaJph)h8h8B*CJOJQJ^JaJphhH{h#CJOJQJaJ%hH{h#B* CJOJQJaJph%hoXh#B* CJOJQJaJphh#B* CJOJQJaJphhjh#5OJQJh :5OJQJh /5OJQJ.Io ' + gd#dgd#<<gdvdgdbgdbdgd :dgd#<gd# $<a$gd#TUlnor}    ϼ߬o`TH5o`H`o`%hfh#B*CJOJQJaJphh#hCJOJQJaJh\^CJOJQJaJhH{h#CJOJQJaJ%hH{h#B* CJOJQJaJphhbB*CJOJQJaJphhbCJOJQJ\aJhfCJOJQJ\aJh8h8CJOJQJ\aJ%hbZh8B* CJOJQJaJphhfB*CJOJQJaJphh8B*CJOJQJaJphh8B* CJOJQJaJph & ' < ? ` u  & ' 0 G K \ ¯zzhzzWIWh;CJOJQJ^JaJ hH{hvCJOJQJ^JaJ#h;B*CJOJQJ^JaJph)hH{hvB*CJOJQJ^JaJphh;B*CJOJQJaJphhH{B*CJOJQJaJph%hH{hvB*CJOJQJaJphh;B* CJOJQJaJph%hH{h#B* CJOJQJaJphhH{h#CJOJQJaJh#hCJOJQJaJ\ ^  - 1 4 _ f v y  ) * + 6 xgR(hH{h#5B* CJOJQJaJph hH{h#CJOJQJ^JaJhH{h#CJaJh;CJOJQJaJhH{hvCJOJQJaJhH{h#CJOJQJaJ%hH{h#B* CJOJQJaJph%hH{hvB*CJOJQJaJphh;CJOJQJ^JaJ hH{hvCJOJQJ^JaJhH{CJOJQJ^JaJ 6 8 Z o { ~    % D H Z c ~ wsh@hiQ5h@aJ#hiQ5B* CJOJQJ^JaJphFDh2hiQ55OJQJ^J7jhiQ5B* CJOJQJU^JaJmHnHphFDuh81jh81UhH{h1wCJaJhH{h#CJOJQJaJhH{h#5CJOJQJaJh;5CJOJQJaJ' IJKL $ 9r a$gd#gdiQ5  9r gdiQ5  2HIJKLhH{h1wCJaJh81h@h@CJOJQJaJ h[h@CJOJQJ^JaJh[h@CJOJQJaJ,1h. A!"#$% nr $?qvy}PNG  IHDR(qsRGB pHYs. . PLTE?ӿl IDATxY qX'qƸ{;BMvIa_Q5~VJۡ\H"7^=įԡ>M<(z 4 ʴ[;2͟1B2,wS(gMr2,ɺW(UPP^=e;}'v<5t6Ҝ^ g0P.)AM4IԵeS(-oNAQ-q+b\fۃnSOjM(G6kPbm"42ڵ_HV5PAFrD~ 0gC 88! 1(3q`ɂn_BaP&HY8,9PeCQxzS~װPjF(Jҝ)7TXÆbb^BFʸPVd gECB|`#r`ZPց#TZ @eP(A3@A7PxBq @׊bFY Ù%]JGpXmE@ eSF= ꔁh@t|(GE@!XX(}~2 tNA0# !JI @)%-Nf(H"ϻd/('Z:U S-wh}IWWr 8R(Vd-*}O+šmM(\vX)(l*(/ᡔTlNj)*-Q/ҡEX)u^S <L-A& $', =&X%җg9EB 'cRa=TA0&T%?ʭ g˓AaL@.)| €PL~ʌEf(p7cA)W"B'ws{H(AQ)PqjV® ;Nٸv\23Pޟ 7? 97t!tNPx)9P + ܏ui {BaI'л24BQa[P:K0\h.)[FP:ZT o(Sd? ]. DrÅS 8׸ ʈ#&ƍgN&V \MEbhO8j̭4kdxB5 㗜4ҹS&glU;? g>gMtT1`(ˡ}t$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] L  %%T \ 6 L  L t ,b$$?qvy}z . @ (  b  # Anew logo#" `?0(  B S  ?  M _Txzyzzz{z|z}z !M 2M>*urn:schemas-microsoft-com:office:smarttags PostalCode>*urn:schemas-microsoft-com:office:smarttags PersonName9 *urn:schemas-microsoft-com:office:smarttagsplaceB*urn:schemas-microsoft-com:office:smarttagscountry-region:*urn:schemas-microsoft-com:office:smarttagsStreet8*urn:schemas-microsoft-com:office:smarttagsCity A*-r}JM.JM3)-.IlJM)-CGJMh}aDhx0#|h}aDhx0EoZg Xx#|Ep oZg Xx%$>$dzdy"F#)iQ5 :Cf#hH{;v-,~Z81\^bbZD2@^m8#:ZQ^gCf8 /1w0@----L@UnknownG*Ax Times New Roman5Symbol3. *Cx Arial7. [ @VerdanaQ. *Microsoft Sans Serif;(SimSun[SOA$BCambria Math"qh&c4c4 a  !243QHP ?#!xx Heparin Oligosaccharidempervez tgallagherOh+'0X     ,8@HPHeparin OligosaccharidempervezNormal tgallagher13Microsoft Office Word@ @@,(@@՜.+,0 hp  PICR  Heparin Oligosaccharide Title  !"#$%'()*+,-/0123458Root Entry F-:1Table"!WordDocument)SummaryInformation(&DocumentSummaryInformation8.CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q